NewRiver REIT plc (LON:NRR)

Market Cap	337.58M
Revenue (ttm)	90.50M
Net Income (ttm)	23.70M
Shares Out	475.47M
EPS (ttm)	0.06
PE Ratio	11.27
Forward PE	8.73
Dividend	0.07 (9.15%)
Ex-Dividend Date	Jun 19, 2025

Volume	702,665
Average Volume	903,871
Open	70.70
Previous Close	71.00
Day's Range	69.90 - 71.40
52-Week Range	62.90 - 85.00
Beta	0.51
RSI	42.89
Earnings Date	Jul 18, 2025

About Inozyme Pharma

NewRiver REIT plc ('NewRiver') is a leading Real Estate Investment Trust specialising in buying, managing and developing resilient retail assets throughout the UK. Following the completion of its acquisition of Capital & Regional in December 2024, NewRiver has a £0.9 billion UK wide portfolio covering 8.2 million sq ft, comprising 28 community shopping centres and 13 conveniently located retail parks occupied by tenants predominately focused on essential goods and services. In addition, we manage 21 shopping centres and 18 retail parks on behal...

• Industry: REIT - Retail
• Sector: Real Estate
• Founded: 2009
• Employees: 250
• Stock Exchange: London Stock Exchange
• Ticker Symbol: NRR

Financial Performance

In 2024, NewRiver REIT's revenue was 90.50 million, an increase of 37.54% compared to the previous year's 65.80 million. Earnings were 23.70 million, an increase of 690.00%.